INOVIO PHARMACEUTICALS, INC. Convertible Debt, Current
INOVIO PHARMACEUTICALS, INC. (INO) had Convertible Debt, Current of $0 as of 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ConvertibleDebtCurrent · last filed 2025-03-18
- 2024-12-31: Convertible Debt, Current $0.00.
- 2024-09-30: Convertible Debt, Current $0.00.
- 2024-06-30: Convertible Debt, Current $0.00.
- 2024-03-31: Convertible Debt, Current $0.00.
| Period end | Convertible Debt, Current |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-18 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-13 |
| 2023-12-31 | $16.77M 10-K · filed 2025-03-18 |
| 2023-09-30 | $16.49M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $16.71M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $16.39M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |